Previous Article | Next Article ![]()
Infection and Immunity, November 2001, p. 6776-6784, Vol. 69, No. 11
Departments of Epidemiology and Public
Health1 and Cell
Biology,2 Yale University School of
Medicine, New Haven, Connecticut
Received 23 October 2000/Returned for modification 13 December
2000/Accepted 23 July 2001
The Leishmania pifanoi amastigote antigen P-8 has
been previously shown to induce protective immunity in a murine model
of cutaneous leishmaniasis (L. Soong, S. M. Duboise, P. Kima, and D. McMahon-Pratt, Infect. Immun. 63:3559-3566, 1995). As
this antigen is of interest for further vaccine studies, the
biochemical characterization of P-8 was undertaken. Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis, Western-blot analysis, and
gel filtration chromatography revealed that P-8 antigen consisted of
two proteoglycolipid complexes. The P-8 epitope is associated with the
L. pifanoi amastigote-specific glycolipid components
found in the two complexes. The P-8 complex 1 (P-8c1) consists of a
56-kDa serine metalloproteinase, apolipoprotein E (derived from
fetal bovine serum), and amastigote-specific glycolipids. The P-8
complex 2 (P-8c2) consists of a 31-kDa cysteine proteinase associated
with amastigote glycolipids. Biochemical analyses suggest that the P-8
antigenic glycolipids may be distinct from previously described
Leishmania glycolipids
(glycosylinositolphospholipids and sphingoglycolipids).
Protective immunity studies revealed that P-8c1 (serine
metalloproteinase-glycolipid complex) confers comparable
protection against infection as immunopurified P-8. The isolated P-8c2
(cysteine proteinase-glycolipid complex) does not provide significant
protection, nor does stimulation with P-8c2 result in significant
T-cell activation in P-8- or P-8c2-vaccinated mice. Consequently, the
P-8c1 complex appears to be the immunodominant component of P-8.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.11.6776-6784.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Biochemical and Biological Characterization of the
Protective Leishmania pifanoi Amastigote Antigen
P-8
and
*
Corresponding author. Mailing address: Yale University
School of Medicine, Department of Epidemiology and Public Health, P.O. Box 208034, 60 College St., New Haven, CT 06510-8034. Phone: (203) 785-4481. Fax: (203) 737-2921. E-mail:
diane.mcmahon-pratt{at}yale.edu.
Present address: Department of Microbiology and Cell Science,
University of Florida, Gainesville, FL 32611-0700.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»